Endothelial Cell-Derived Exosomes Inhibit Osteoblast Apoptosis and Steroid-Induced Necrosis of Femoral Head Progression by Activating the PI3K/Akt/Bcl-2 Pathway
Journal of Tissue Engineering and Regenerative Medicine · 2024
DOI: 10.1155/2024/3870988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, 2024. Verfasst von Jie Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Osteoblasts, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Province Senile Health Scientific Research Project, Scientific Research Project of Nantong Health Commission.
Abstract (Originalsprache)
The aim of the study was to investigate the therapeutic potential of exosomes secreted by endothelial cells (EC-exos) on steroid-induced osteonecrosis of femoral head (SNFH). First, we successfully obtained EC-exos through differential centrifugation. Then, the effects of EC-exos on mouse embryo osteoblast precursor (MC3T3-E1) cells under high concentration of dexamethasone (Dex) were analysed in vitro, which included cell migration, viability, and apoptosis. In vivo, a SNFH rat model was successfully established and treated with EC-exos. Micro-computed tomography (micro-CT) and haematoxylin and eosin (H&E) were used to observe femoral trabeculae. Our in vitro results showed that EC-exos improved cell viability and migration of osteoblasts and reduced the apoptotic effect of high concentration of Dex on osteoblasts in vitro. Phosphoinositide 3-kinase (PI3K)/Akt/Bcl-2 signalling pathway was activated in MC3T3-E1 cells under the response to EC-exos. In vivo, increased bone volume per tissue volume (BV/TV) p = 0.031 , trabecular thickness (Tb.Th) p = 0.020 , and decreased separation (Tb.Sp) p = 0.040 were observed in SNFH rats treated with EC-exos. H&E staining revealed fewer empty lacunae and pyknotic osteocytes in trabeculae. The expression of Bcl-2 and Akt in EC-exos group was significantly increased in trabeculae tissue. Overall, our finding indicated that EC-exos could attenuate SNFH by inhibiting osteoblast apoptosis via the PI3K/Akt/Bcl-2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
- Research Centre of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
- Department of Geriatrics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
ORCID-Profile: Jie Sun, Wenjie Zheng, Chi Sun, Yafeng Zhang
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Senile Health Scientific Research Project
- Scientific Research Project of Nantong Health Commission
- Science and Technology Project of Nantong City
- Jiangsu Provincial Research Hospital
Zitieren
APA
Sun, J., Yao, C., Luo, W., Ge, X., Zheng, W., Sun, C., & Zhang, Y. (2024). Endothelial Cell-Derived Exosomes Inhibit Osteoblast Apoptosis and Steroid-Induced Necrosis of Femoral Head Progression by Activating the PI3K/Akt/Bcl-2 Pathway. Journal of Tissue Engineering and Regenerative Medicine. https://doi.org/10.1155/2024/3870988
Vancouver
Sun J, Yao C, Luo W, Ge X, Zheng W, Sun C, et al. Endothelial Cell-Derived Exosomes Inhibit Osteoblast Apoptosis and Steroid-Induced Necrosis of Femoral Head Progression by Activating the PI3K/Akt/Bcl-2 Pathway. Journal of Tissue Engineering and Regenerative Medicine. 2024. doi:10.1155/2024/3870988
BibTeX
@article{Sun2024,
author = {Sun, Jie and Yao, Chen and Luo, Wanxin and Ge, Xingyu and Zheng, Wenjie and Sun, Chi and Zhang, Yafeng},
title = {Endothelial Cell-Derived Exosomes Inhibit Osteoblast Apoptosis and Steroid-Induced Necrosis of Femoral Head Progression by Activating the PI3K/Akt/Bcl-2 Pathway},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2024},
doi = {10.1155/2024/3870988}
}
EUVIMED